Showing results (151-160 of 292) with videos related to

Sort By:
Pageof 30
Medicines (Basel, Switzerland)|August 7, 2019
Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care CenterAmy H Huang, Benjamin H Kaffenberger, Adam Reich, et al.
Brain Research Bulletin|June 2, 2009
Predominant CB2 receptor expression in endothelial cells of glioblastoma in humansMarcus Schley, Sonja Ständer, John Kerner, et al.
Journal of the American Academy of Dermatology|March 22, 2019
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trialSonja Ständer, Paul Kwon, Joe Hirman, et al.
Acta Dermato-Venereologica|August 7, 2019
Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis VulgarisSonja Ständer, Sabine Steinke, Matthias Augustin, et al.
Dermatologic Therapy|April 17, 2019
Woad extract containing cream improves significantly dry, irritated, and pruritic skinCaroline Forner, Claudia Zeidler, Philipp Stein, et al.
The Journal of Investigative Dermatology|September 1, 2024
Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 InflammationShawn G Kwatra, Sonja Ständer, Gil Yosipovitch, et al.
The Journal of Investigative Dermatology|May 4, 2007
Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesisAnke Rattenholl, Stephan Seeliger, Jörg Buddenkotte, et al.
Acta Dermato-Venereologica|January 16, 2020
Challenges in Clinical Research and Care in PruritusManuel P Pereira, Claudia Zeidler, Michael Storck, et al.
Pageof 30